Compare CCEL & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | RMTI |
|---|---|---|
| Founded | 1989 | 1994 |
| Country | United States | United States |
| Employees | N/A | 300 |
| Industry | Managed Health Care | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 32.2M |
| IPO Year | 2022 | 2022 |
| Metric | CCEL | RMTI |
|---|---|---|
| Price | $4.26 | $8.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 21.0K | ★ 27.6K |
| Earning Date | 04-14-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | $25,384,279.00 | ★ $69,258,000.00 |
| Revenue This Year | N/A | $8.64 |
| Revenue Next Year | N/A | $8.44 |
| P/E Ratio | $61.14 | ★ N/A |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $2.72 | $0.55 |
| 52 Week High | $5.01 | $8.50 |
| Indicator | CCEL | RMTI |
|---|---|---|
| Relative Strength Index (RSI) | 58.58 | 60.40 |
| Support Level | $3.10 | $0.79 |
| Resistance Level | $4.41 | $8.50 |
| Average True Range (ATR) | 0.31 | 0.41 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 38.46 | 43.93 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.